Clinical Trial Update: A Study of the Safety and Efficacy of CNTO 888 in Combination With SoC (Standard of Care) Chemotherapy in Patients With Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and preliminary efficacy of CNTO 888 in combination with standard-of-care chemotherapy in patients with solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• CNTO 888

Snippet

Sponsor: Centocor, Inc. | Conditions: Cancer | Phase 1 | Status: COMPLETED